UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 861177
NEW YORK, NY
Position in ACAD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,903,220
+$1,297,985 QoQ
Shares Held
233,329
+12.8% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 354 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 44%
Shared 0%
None 56%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. ACAD ranks #57 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in ACAD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,903,220 | 233,329 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,605,235 | 206,884 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,487,111 | 205,433 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,505,190 | 211,115 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,395,962 | 342,882 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,170,037 | 251,056 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $4,020,940 | 219,125 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,918,183 | 189,739 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,535,917 | 217,595 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,206,651 | 119,343 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,830,713 | 122,348 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,474,602 | 118,743 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,032,427 | 126,615 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,382,892 | 126,615 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $2,015,567 | 123,201 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,658,824 | 614,537 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $13,862,194 | 572,345 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $12,650,114 | 541,993 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,703,849 | 463,808 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,827,610 | 484,937 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $10,413,523 | 403,625 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $30,731,211 | 574,845 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $24,326,196 | 589,726 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $44,575,626 | 919,654 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $32,769,183 | 775,602 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||